Annual Review

2017: The Second Coming of Cardiovascular Disease
‘The alarming reality is that Australia is now entering the early stages of a renewed cardiovascular disease epidemic.’

The fight against cardiovascular disease is a neverending journey.

Despite huge progress in prevention and treatment over the past 50 years, heart disease remains Australia’s number one killer. The core mission of the HRI – to improve our understanding of the causes and complications of heart disease – therefore remains essential.

                       For a hard copy of the 2017 Annual Review, please email our communications team

  1. Financial Statement 

  2. The Heart Research Institute has a strong balance sheet and a solid asset base. This is important so as to smooth any fluctuations in income in any single year and enable our scientific staff to have greater security of tenure. HRI are Currently fundraising in five international markets: Australia, New Zealand, The United Kingdom, The Netherlands and Canada.